Community Healthcare Trust cut its quarterly dividend to $0.33 after second-quarter earnings and revenue fell short of expectations. On October 2, shares closed near their 52-week low.
CHCT shares closed at $13.62 on October 2, down 3.34% from the previous close. That was just $0.39 above the 52-week low.
Community Healthcare Trust cut its quarterly dividend from $0.48 to $0.33, according to a MarketBeat dividend update. The cut matters.
The dividend now totals $1.32 a year, for a reported yield of 9.3%. The payout ratio was 197.01%. That figure makes the headline yield a poor measure of the stock on its own. The reported information does not say how the ratio was calculated, so investors should not treat it as a direct measure of cash available for distributions.
CHCT completed a 1-for-249 reverse stock split on August 1, 2025.
For shareholders seeking income, the main point is simple: the quarterly cash payment is lower, even though the quoted yield remains high.
The quarterly results add reason to look closely at the payout. For the quarter ended June 30, diluted earnings per share were $0.06, below the $0.11 consensus estimate. Revenue was $30.97 million, compared with $31.77 million expected, according to a MarketBeat earnings recap.
The company also filed its Q2 2026 results with the SEC in a current report covering the period ended June 30. Its healthcare-related properties make rental income, occupancy and financing costs central to its earnings picture. The reported results do not identify which factor drove the shortfall.
The SEC filing records a second reverse stock split, at a ratio of 1-for-60, completed on February 10, 2026. Together, the two split events are important context when comparing per-share figures across periods.
The share price weakness extends beyond a single day's move. At $13.62, CHCT was $5.55 below its 52-week high of $19.17. Market capitalization was $389.1 million. Trading volume reached 527,640 shares on October 2.
Analyst views offer a different perspective, but do not settle the question. Five brokerages had an average Hold rating: three Holds and two Buys. Their average 12-month target was $18.50, or 35.8% above the October 2 share price.
On August 6, Piper Sandler lowered its target from $20 to $17 and assigned a Neutral rating. Targets are estimates, not promised returns. They do not restore the dividend.
Other income-stock cases have a similar tension, though the details differ. Another REIT payout case showed how a distribution can conflict with property-level risks. For CHCT, the immediate facts are more direct: the company cut its dividend as earnings and revenue missed estimates.
Investors weighing the income case should consider the lower quarterly payment, the reported payout ratio and the earnings miss alongside the yield. The gap between the share price and analysts' average target may draw attention. But a target is a forecast, not evidence that the dividend or operating results will recover.
A dividend yield compares the annualized payment with the share price. It can rise when the price falls, even if the company's cash distribution has not improved. A dividend cut changes the payment itself. A high reported payout ratio may signal that a distribution is hard to sustain, depending on how the ratio is calculated. These measures answer different questions. A high quoted yield alone does not show that an income investment is strong.
CHCT now pays less each quarter after a disappointing quarter, and its shares trade near their yearly low. The higher broker target offers another view of the stock's value, but it does not erase those facts. Until earnings and payout capacity look more convincing, investors should read the reported yield as compensation for risk, not proof of dependable income.
